NK22 cells in the uterine mid-secretory endometrium and peripheral blood of women with recurrent pregnancy loss and unexplained infertility

American Journal of Reproductive Immunology

Volumn 73, Issue 6, 2015, Pages 557-567

  Kamoi, Mai ^a   Fukui, Atsushi ^a   Kwak Kim, Joanne ^b   Fuchinoue, Kohei ^a   Funamizu, Ayano ^a   Chiba, Hitomi ^a   Yokota, Megumi ^a   Fukuhara, Rie ^a   Mizunuma, Hideki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cytokine; Human uterine endometrium; IL 22; NK cell; NK22 cell; RPL

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; MEMBRANE ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NCAM1 PROTEIN, HUMAN; NCR1 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOTOXICITY; ENDOMETRIUM CELL; FEMALE; FEMALE INFERTILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MAJOR CLINICAL STUDY; NATURAL KILLER 22 CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT ABORTION; UNEXPLAINED INFERTILITY; UNEXPLAINED RECURRENT PREGNANCY LOSS; CLINICAL TRIAL; ENDOMETRIUM; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD56; CYTOKINES; ENDOMETRIUM; FEMALE; FLOW CYTOMETRY; HUMANS; INFERTILITY, FEMALE; KILLER CELLS, NATURAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PREGNANCY;

EID: 84929273985     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12356     Document Type: Article

References (50)

1. King A, Balendran N, Wooding P, Carter NP, Loke YW: CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56 + + population. Dev Immunol 1991; 1:169-190.
2. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
3. Caligiuri MA: Human natural killer cells. Blood 2008; 112:461-469.
4. Tang AW, Alfirevic Z, Quenby S: Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011; 26:1971-1980.
5. Moffett A, Regan L, Braude P: Natural killer cells, miscarriage, and infertility. BMJ 2004; 329:1283-1285.
6. Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y: Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol 1999; 41:413-422.
7. Seshadri S, Sunkara SK: Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 2014; 20:429-438.
8. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I: Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15:1163-1169.
9. Lee SK, Na BJ, Kim JY, Hur SE, Lee M, Gilman-Sachs A, Kwak-Kim J: Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am J Reprod Immunol 2013; 70:398-411.
10. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156:4027-4034.
11. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, Robson SC, Bulmer JN: Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 2006; 80:572-580.
12. Zhang J, Chen Z, Smith GN, Croy BA: Natural killer cell-triggered vascular transformation: maternal care before birth? Cell Mol Immunol 2011; 8:1-11.
13. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998; 161:5821-5824.
14. Higuma-Myojo S, Sasaki Y, Miyazaki S, Sakai M, Siozaki A, Miwa N, Saito S: Cytokine profile of natural killer cells in early human pregnancy. Am J Reprod Immunol 2005; 54:21-29.
15. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J, Faas MM: Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril 2002; 77:1032-1037.
16. Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL: Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol 2005; 35:3054-3063.
17. Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee SK, Beaman K: Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 2008; 89:157-165.
18. Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, Moretta L, Dimasi N: Human natural killer cell receptors: insights into their molecular function and structure. J Cell Mol Med 2003; 7:376-387.
19. Fukui A, Ntrivalas E, Gilman-Sachs A, Kwak-Kim J, Lee SK, Levine R, Beaman K: Expression of natural cytotoxicity receptors and a2V-ATPase on peripheral blood NK cell subsets in women with recurrent spontaneous abortions and implantation failures. Am J Reprod Immunol 2006; 56:312-320.
20. Fukui A, Ntrivalas E, Fukuhara R, Fujii S, Mizunuma H, Gilman-Sachs A, Beaman K, Kwak-Kim J: Correlation between natural cytotoxicity receptors and intracellular cytokine expression of peripheral blood NK cells in women with recurrent pregnancy losses and implantation failures. Am J Reprod Immunol 2009; 62:371-380.
21. Yokota M, Fukui A, Funamizu A, Nakamura R, Kamoi M, Fuchinoue K, Sasaki Y, Fukuhara R, Mizunuma H: Role of NKp46 expression in cytokine production by CD56-positive NK cells in the peripheral blood and the uterine endometrium. Am J Reprod Immunol 2013; 69:202-211.
22. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M: A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-725.
23. Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP: The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol 2009; 183:6579-6587.
24. Male V, Hughes T, McClory S, Colucci F, Caligiuri MA, Moffett A: Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010; 185:3913-3918.
25. Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E: Influence of the transcription factor RORgammat on the development of NKp46 + cell populations in gut and skin. Nat Immunol 2009; 10:75-82.
26. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A: RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46 + cells. Nat Immunol 2009; 10:83-91.
27. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP: Microbial flora drives interleukin 22 production in intestinal NKp46 + cells that provide innate mucosal immune defense. Immunity 2008; 29:958-970.
28. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
29. Pirhonen J, Matikainen S, Julkunen I: Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 2002; 169:5673-5678.
30. Tchatalbachev S, Ghai R, Hossain H, Chakraborty T: Gram-positive pathogenic bacteria induce a common early response in human monocytes. BMC Microbiol 2010; 10:275.
31. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W: Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-289.
32. Stacey MA, Marsden M, Pham NT, Clare S, Dolton G, Stack G, Jones E, Klenerman P, Gallimore AM, Taylor PR, Snelgrove RJ, Lawley TD, Dougan G, Benedict CA, Jones SA, Wilkinson GW, Humphreys IR: Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. Cell Host Microbe 2014; 15:471-483.
33. Dumoutier L, Van Roost E, Colau D, Renauld JC: Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97:10144-10149.
34. Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP: Gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med 2010; 207:2239-2253.
35. Witte E, Witte K, Warszawska K, Sabat R, Wolk K: Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 2010; 21:365-379.
36. Yang X, Zheng SG: Interleukin-22: a likely target for treatment of autoimmune diseases. Autoimmun Rev 2014; 13:615-620.
37. Zenewicz LA, Flavell RA: Recent advances in IL-22 biology. Int Immunol 2011; 23:159-163.
38. Kumar P, Rajasekaran K, Palmer JM, Thakar MS, Malarkannan S: IL-22: an evolutionary missing-link authenticating the role of the immune system in tissue regeneration. J Cancer 2013; 4:57-65.
39. Cella M, Otero K, Colonna M: Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010; 107:10961-10966.
40. Wang Y, Xu B, Li MQ, Li DJ, Jin LP: IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts. Int J Clin Exp Pathol 2013; 6:1781-1790.
41. Lash GE, Otun HA, Innes BA, Kirkley M, De Oliveira L, Searle RF, Robson SC, Bulmer JN: Interferon-gamma inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels. FASEB J 2006; 20:2512-2518.
42. Terranova PF, Hunter VJ, Roby KF, Hunt JS: Tumor necrosis factor-alpha in the female reproductive tract. Proc Soc Exp Biol Med 1995; 209:325-342.
43. Funamizu A, Fukui A, Kamoi M, Fuchinoue K, Yokota M, Fukuhara R, Mizunuma H: Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis. Am J Reprod Immunol 2014; 71:359-367.
44. Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, Kimura H, Mizunuma H: Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol, 2011/06/03 edn 2011; 90:105-110.
45. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M: Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol 1993; 5:559-563.
46. Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD, Koopman LA, Strominger JL: TGFbeta promotes conversion of CD16 + peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA 2007; 104:3378-3383.
47. Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer? Nat Rev Immunol 2003; 3:413-425.
48. Vacca P, Vitale C, Montaldo E, Conte R, Cantoni C, Fulcheri E, Darretta V, Moretta L, Mingari MC: CD34 + hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc Natl Acad Sci 2011; 108:2402-2407.
49. Manaster I, Mandelboim O: The unique properties of human NK cells in the uterine mucosa. Placenta 2008; 29 (Suppl A):S60-S66.
50. Jabrane-Ferrat N, Siewiera J: The up side of decidual natural killer cells: new developments in immunology of pregnancy. Immunology 2014; 141:490-497.